Loading...
Loading...
SMFR| Name | Value |
|---|---|
| Revenues | 43.1M |
| Cost of Revenue | 27.9M |
| Gross Profit | 15.2M |
| Operating Expense | 73.5M |
| Operating I/L | -58.2M |
| Other Income/Expense | -0.8M |
| Interest Income | 0.7M |
| Pretax | -61.1M |
| Income Tax Expense | -0.1M |
| Net Income/Loss | -61.0M |
Sema4 Holdings Corp., operating as Sema4, is a health information company specializing in enhancing disease diagnosis, treatment, and prevention through data. The company offers Centrellis, an AI-driven health intelligence platform providing comprehensive insights to biopharma for drug discovery, development, and commercialization. Additionally, it provides Sema4 Signal for precision oncology care, including testing for carrier screening, prenatal and newborn screening, and hereditary cancer testing. Sema4 also offers COVID-19 testing solutions, contributing to its revenue stream.
